Cargando…
Response of Mycobacterium smegmatis to the Cytochrome bcc Inhibitor Q203
For the design of next-generation tuberculosis chemotherapy, insight into bacterial defence against drugs is required. Currently, targeting respiration has attracted strong attention for combatting drug-resistant mycobacteria. Q203 (telacebec), an inhibitor of the cytochrome bcc complex in the mycob...
Autores principales: | Chauhan, Priyanka, van der Meulen, Santhe Amber, Simões Caetano, João Miguel, Goojani, Hojjat Ghasemi, Botman, Dennis, van Spanning, Rob, Lill, Holger, Bald, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498996/ https://www.ncbi.nlm.nih.gov/pubmed/36142240 http://dx.doi.org/10.3390/ijms231810331 |
Ejemplares similares
-
The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd
por: Lu, Ping, et al.
Publicado: (2018) -
The cytochrome bd-type quinol oxidase is important for survival of
Mycobacterium smegmatis under peroxide and antibiotic-induced stress
por: Lu, Ping, et al.
Publicado: (2015) -
Cardiolipin enhances the enzymatic activity of cytochrome bd and cytochrome bo(3) solubilized in dodecyl-maltoside
por: Asseri, Amer H., et al.
Publicado: (2021) -
Isolation and Characterization of a Hybrid Respiratory Supercomplex Consisting of Mycobacterium tuberculosis Cytochrome bcc and Mycobacterium smegmatis Cytochrome aa(3)*
por: Kim, Mi-Sun, et al.
Publicado: (2015) -
Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates
por: Zhou, Shan, et al.
Publicado: (2021)